TGFB1 and cancer: Indeed, the combination of the ubiquitous expression of TGFβ ligands, lack of dosing regimens, and its dual role in tumourigenesis pose a challenge to utilizing TGFβ antagonists in cancer therapy (Sheen et al., 2013).